Showing results (41-50 of 207) with videos related to
Sort By:
Pageof 21
Thrombosis and Haemostasis|January 12, 2001
Characterization of unfractionated heparin: comparison of materials from the last 50 yearsB Mulloy, E Gray, T W BarrowcliffeBlood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|December 1, 1990
Monoclonal antibodies against antithrombin III and their application in an immunoradiometric assayJ Watton, M Baines, T W BarrowcliffeThrombosis and Haemostasis|April 30, 1982
A comparison of pentosan polysulphate and heparin. II: Effects of subcutaneous injectionA M Fischer, R E Merton, N A Marsh, et al.Haemophilia : the Official Journal of the World Federation of Hemophilia|January 5, 1999
Discrepancies in potency assessment of recombinant FVIII concentratesT W Barrowcliffe, S Raut, A R HubbardThrombosis Research|July 15, 1982
Studies of anti-Xa activity in human plasma. II: The role of lipoproteinsT W Barrowcliffe, C A Eggleton, J StocksThrombosis and Haemostasis|July 4, 2001
A collaborative study to establish the 6th International Standard for factor VIII concentrateS Raut, A B Heath, T W BarrowcliffeHaemophilia : the Official Journal of the World Federation of Hemophilia|June 26, 2012
Standards and monitoring treatmentT W Barrowcliffe, A R Hubbard, S KitchenThe Journal of Laboratory and Clinical Medicine|January 1, 1983
Binding to phospholipid protects factor VIII from inactivation by human antibodiesT W Barrowcliffe, G Kemball-Cook, E GrayThrombosis and Haemostasis|May 9, 2001
Standardisation of factor VIII and von Willebrand factor in plasma: calibration of the 4th International Standard (97/586)A R Hubbard, P Rigsby, T W BarrowcliffeBritish Journal of Haematology|September 1, 1983
Studies of the heterogeneity of antithrombin III concentratesT W Barrowcliffe, C A Eggleton, M MahmoudPageof 21